Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of leap-2 (human, mature 38-77) in China, also supports custom service. Welcome to wholesale bulk high quality leap-2 (human, mature 38-77) from our factory. Contact us for more details.
| Description | LEAP-2 (CAS: 1683582-94-6) is the 40-residue mature cationic AMP produced by furin-like cleavage of the human 77-aa precursor, sequence MTPFWRGVSLRPIGASCRDNSECITRLCRKRRCSLSVAQE, stabilized by Cys17-Cys28 and Cys23-Cys33 disulfide bridges. Synthesized mainly in liver and detected in small intestine and blood, LEAP-2 shows dose-dependent cidal activity against E. coli and Candida; it is also an endogenous high-affinity antagonist of the ghrelin receptor GHS-R1a, competitively blocking ghrelin-induced growth-hormone secretion and appetite, directly linking innate immunity to energy metabolism. LEAP-2 is a dual-function tool for hepatic AMPs, the gut-liver axis, and ghrelin/GHS-R1a metabolic regulation. |
| Structure type | 40-residue cationic cyclic peptide (two disulfide bonds; human hepatic AMP / GHS-R1a antagonist) |
| Solubility | Readily soluble in water, dilute acetic acid |
| Storage | Powder -20C, dry, protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| LEAP-2 (human, mature 38-77) | Human LEAP-2 (38-77); Liver-expressed Antimicrobial Peptide 2; LEAP2; 40-aa mature peptide; endogenous GHS-R1a antagonist; CAS:1683582-94-6 | liver-derived AMP, cysteine-rich, disulfide-stabilized, cationic AMP, GHS-R1a antagonist, metabolic regulation, 40-mer, free base, Met oxidation-sensitive, anti-Gram-positive/yeast | 40-aa mature peptide (cleaved from residues 38-77 of the human LEAP-2 precursor), sequence MTPFWRGVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE; free N-terminus +1, 7 Arg + 1 Lys (+8), 2 Asp + 2 Glu (-4), free C-terminal Glu -1, net charge ~+4, predicted pI ~9.2; 4 Cys form two disulfide bonds (Cys17-Cys28 and Cys23-Cys33, 1-3/2-4 pairing) forming a compact cystine core; also contains one N-terminal Met (oxidation-sensitive), one Trp5 (fluorescent probe), two Pro (conformational restriction); ~35% hydrophobic residues (M/T/F/W/V/L/I/P/A); redox state (oxidized vs linear) strongly affects membrane penetration and DNA binding | C191H316N64O57S5 | 4578.24 | 4581.32 | Free base (no TFA salt) | 40 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-LEAP2-01 | White powder | -20°C, desiccated, sealed, light-protected; contains two disulfide bonds so avoid reducing agents (DTT/TCEP/β-ME) and repeated freeze-thaw to prevent disulfide scrambling; N-terminal Met is oxidation-sensitive, flush with argon/nitrogen | 2-8°C, desiccated and light-protected, stable for 1-2 weeks | Cationic peptide (net +4, pI ~9.2), moderate aqueous solubility; first dissolve in a small volume of sterile water or dilute acetic acid (0.01% AcOH), then dilute in PBS; avoid reducing-agent-containing buffers; aliquot and store solutions at -20°C, avoid freeze-thaw to prevent disulfide rearrangement; prepare fresh due to Met oxidation; avoid long-term co-storage with concentrated metal ions | Disulfide structure is relatively stable in the solid, but long-term storage still requires dry, -20°C, inert-gas-sealed; protect from moisture to prevent Met oxidation and disulfide exchange; hygroscopic, seal tightly |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-LEAP2-01 | A 40-aa cysteine-rich cationic antimicrobial peptide secreted by human liver (MTPFWRGVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE), two disulfide bonds, net +4; combines anti-Gram-positive/yeast activity with endogenous GHS-R1a antagonism for metabolic regulation. | LEAP-2 (Liver-expressed Antimicrobial Peptide 2) is a cysteine-rich cationic antimicrobial peptide isolated by Krause et al. in 2003 from human blood ultrafiltrate. It is synthesized as a 77-aa liver precursor that is cleaved by a furin-like endoprotease to the largest circulating form, the 40-aa mature peptide LEAP-2 (38-77). The primary sequence is highly conserved among mammals; four Cys residues pair in a 1-3/2-4 pattern (Cys17-Cys28, Cys23-Cys33) to form a compact disulfide-stabilized core critical for both antimicrobial activity and receptor recognition. In vitro, oxidized LEAP-2 exerts dose-dependent killing of Gram-positive bacteria such as S. aureus and yeasts such as C. albicans; the linear reduced form penetrates membranes and binds DNA more readily but is rapidly cleared in vivo. Over the past decade, LEAP-2 has emerged not only as an innate immune effector but as a key metabolic peptide: it is a potent endogenous inverse agonist/antagonist of the ghrelin receptor GHS-R1a, blocking ghrelin's orexigenic signal to suppress appetite, regulate glucose and insulin sensitivity, and modulate growth hormone secretion, making it a candidate target for obesity and type 2 diabetes. LEAP-2 also participates in liver-gut axis immune surveillance, sepsis-phase immunomodulation and tumor microenvironment regulation. This product is a chemically synthesized human 40-mer with correctly paired disulfides, suitable for AMP SAR studies, GHS-R1a ligand screening, metabolic disease models and innate immunity research. | hepatic innate immunity, cysteine-rich AMPs, GHS-R1a antagonists, metabolism and appetite regulation, anti-Gram-positive/yeast, disulfide-stabilized peptides, obesity/T2D drug targets, sepsis immunomodulation | bacterial membranes, fungal membranes, GHS-R1a (growth hormone secretagogue receptor 1a), ghrelin receptor signaling |
Hot Tags: leap-2 (human, mature 38-77), China leap-2 (human, mature 38-77) manufacturers, suppliers, factory, 79404-91-4, CAS 849352 44 9, Cilofungin, Combi-1, Elf18, Temporin K
